HealthSouth Corporation (NYSE:HLS)‘s stock had its “hold” rating reaffirmed by equities researchers at Piper Jaffray Companies in a research report issued on Thursday. They currently have a $50.00 price target on the stock. Piper Jaffray Companies’ target price suggests a potential upside of 17.23% from the company’s previous close.

Several other equities analysts have also issued reports on the stock. Zacks Investment Research downgraded shares of HealthSouth Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, April 25th. Barclays PLC restated an “underweight” rating and issued a $46.00 target price (up from $44.00) on shares of HealthSouth Corporation in a research note on Monday, May 1st. ValuEngine downgraded shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. BidaskClub upgraded shares of HealthSouth Corporation from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Finally, KeyCorp initiated coverage on shares of HealthSouth Corporation in a research note on Thursday, June 15th. They issued a “sector weight” rating for the company. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $48.83.

Shares of HealthSouth Corporation (HLS) traded up 0.19% during trading on Thursday, reaching $42.65. The company’s stock had a trading volume of 807,756 shares. The stock has a market cap of $3.85 billion, a P/E ratio of 15.54 and a beta of 0.61. The stock’s 50-day moving average is $46.56 and its 200-day moving average is $44.10. HealthSouth Corporation has a 12-month low of $36.97 and a 12-month high of $49.71.

HealthSouth Corporation (NYSE:HLS) last issued its earnings results on Monday, July 31st. The company reported $0.71 EPS for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.03. The business had revenue of $981.30 million for the quarter, compared to analyst estimates of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period last year, the company posted $0.69 earnings per share. Equities research analysts anticipate that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.

WARNING: “HealthSouth Corporation (HLS) Rating Reiterated by Piper Jaffray Companies” was originally published by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/08/06/healthsouth-corporation-hls-rating-reiterated-by-piper-jaffray-companies.html.

In related news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $42.55, for a total transaction of $962,693.75. Following the transaction, the chief executive officer now directly owns 283,134 shares in the company, valued at $12,047,351.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.60% of the stock is owned by insiders.

A number of institutional investors have recently bought and sold shares of the stock. Wellington Management Group LLP raised its position in HealthSouth Corporation by 4,377.7% in the first quarter. Wellington Management Group LLP now owns 995,082 shares of the company’s stock valued at $42,599,000 after buying an additional 972,859 shares during the last quarter. Mackay Shields LLC purchased a new position in HealthSouth Corporation during the second quarter valued at $39,641,000. William Blair Investment Management LLC raised its position in HealthSouth Corporation by 13.9% in the second quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock valued at $208,253,000 after buying an additional 525,767 shares during the last quarter. Marshall Wace North America L.P. raised its position in HealthSouth Corporation by 311.3% in the second quarter. Marshall Wace North America L.P. now owns 560,568 shares of the company’s stock valued at $26,907,000 after buying an additional 424,280 shares during the last quarter. Finally, Deprince Race & Zollo Inc. purchased a new position in HealthSouth Corporation during the first quarter valued at $16,129,000. Institutional investors own 97.76% of the company’s stock.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.